Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.19.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2019
Jun. 30, 2018
Current assets :    
Cash $ 37,446 $ 48,440
Accounts receivable - net 85,604
Inventories 314,966 103,209
Other current assets 22,019 3,210
Total current assets 460,035 154,859
Total assets 460,035 154,859
Current liabilities:    
Accounts payable 284,845 215,782
Accrued expense-related party 45,974 197,974
Convertible notes payable - net of discount 741,959 633,870
Fair value of derivative liabilities 970,010 1,765,187
Short-term borrowings 1,000
Total current liabilities 2,042,788 2,813,813
Commitments and contingencies
Stockholders' deficit:    
Common stock, ($0.001 par value, 200,000,000 shares authorized, and 52,980,943 issued and outstanding as of March 31, 2019 and 42,608,329 outstanding as of June 30, 2018, respectively) 52,981 42,608
Additional paid in capital 10,167,577 5,919,152
Accumulated deficit (11,803,311) (8,620,714)
Total stockholders' deficit (1,582,753) (2,658,954)
Total Liabilities and Stockholders' Deficit $ 460,035 $ 154,859